News Search Results
Mar 20, 2025, 08:00 ET Elevation Oncology to Discontinue Development of EO-3021; Advancing EO-1022, While Evaluating Strategic Options
Elevation Oncology cannot guarantee future events, results, actions, levels of activity, performance or achievements, and the timing and results of biotechnology development and potential regulatory approval are inherently uncertain. Forward-looking statements are subject to risks and uncertainties that may
More news about: Elevation Oncology
Mar 20, 2025, 07:31 ET MetaVia Reports Year End 2024 Financial Results and Provides Corporate Update
March 20, 2025 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced financial results for the year ended December 31,
More news about: MetaVia Inc.
Mar 20, 2025, 07:00 ET Marengo Therapeutics Enters Multi-Year Collaboration With University of Pennsylvania Institute for Immunology and Immune Health to Advance Next Wave Precision T Cell Immunology Research in Oncology and Autoimmune Diseases
March 20, 2025 /PRNewswire/ -- Marengo Therapeutics, Inc., a clinical-stage biotechnology company pioneering novel discovery of reprogramming T cell repertoire for precision immunotherapy in oncology and autoimmune diseases, today announced
More news about: Marengo Therapeutics
Mar 20, 2025, 05:04 ET ICON Public Limited Company Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before April 11, 2025 to Discuss Your Rights - ICLR
insufficient to shield the Company from the adverse effects of a significant market downturn; (c) the requests for proposals ICON received from its biotechnology customers during the Class Period were used in substantial part as price discovery tools, and thus were not indicative of underlying client demand;
More news about: The Gross Law Firm
Mar 20, 2025, 04:30 ET Versameb AG Announces Grant of First Patent in China for "Signal Peptide with Heterologous Protein"
which a sling is permanently implanted into the urethra or bladder neck. About Versameb AG Versameb AG is a privately held biotechnology company focused on discovering and developing innovative RNA-based therapeutics. Founded in Basel in 2018, Versameb
More news about: Versameb AG
Mar 20, 2025, 04:30 ET Infinitopes Strengthens Board with Two Biotech Leaders to Advance Precision Immunotherapies into the Clinic
cancer centres in the first half of 2025. About Infinitopes Infinitopes Ltd is a soon to be clinical stage, integrated cancer biotechnology company supported by Cancer Research UK (CRUK) and the University of Oxford. The Company combines two world leading
More news about: Infinitopes
Mar 20, 2025, 03:31 ET Aquaporin announces full-year 2024 results
-- Aquaporin A/S (CSE: AQP) ("Aquaporin" or the "Company"), an innovative water technology company dedicated to rethinking water filtration with biotechnology, today announces the Annual Report for the period January 1 to December 31, 2024. "Notwithstanding the
More news about: Aquaporin A/S
Mar 20, 2025, 03:26 ET Aquaporin announces full-year 2024 results
-- Aquaporin A/S (CSE: AQP) ("Aquaporin" or the "Company"), an innovative water technology company dedicated to rethinking water filtration with biotechnology, today announces the Annual Report for the period January 1 to December 31, 2024. "Notwithstanding the
More news about: Aquaporin A/S
Mar 20, 2025, 03:00 ET Brainomix Completes £14M ($18M) Series C Round to Advance Its Transformative AI Imaging Technology in Healthcare
Ingelheim Venture Fund GmbHThe Boehringer Ingelheim Venture Fund (BIVF), established in 2010, is dedicated to investing in groundbreaking biotechnology companies that are at the forefront of therapeutic and digital innovations, aiming to advance biomedical research. With a commitment to revolutionizing
More news about: Brainomix
Mar 19, 2025, 23:41 ET BenQ Medical Technology and Brain Navi Align Partnership to Advance Neurosurgical Robotics in China
ZHUBEI, March 19, 2025 /PRNewswire/ -- Brain Navi Biotechnology, a leading innovator in neurosurgical robotics, has announced a strategic partnership with BenQ Medical Technology to introduce and commercialize
More news about: Brain Navi
Mar 19, 2025, 19:12 ET ICLR Purchasers Have Opportunity to Lead ICON plc Securities Fraud Lawsuit
were insufficient to shield ICON from the adverse effects of a significant market downturn; (3) the requests for proposals ICON received from its biotechnology customers during the Class Period were used in substantial part as price discovery tools, and thus were not indicative of underlying client demand;
More news about: THE ROSEN LAW FIRM, P. A.
Mar 19, 2025, 13:30 ET Landmark Study Explains Why Obesity Drugs Work Differently for Women and Men
will help millions of women have a better solution without the side effects." About Olio Labs Olio Labs is a next-generation biotechnology company pioneering AI-driven therapeutic design. By fusing advanced computational methods with nuanced biological insights and cutting-edge technology,
More news about: Olio Labs
Mar 19, 2025, 12:00 ET ICON plc (ICLR) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
offerings were insufficient to shield the Company from the adverse effects of a significant market downturn; (3) that the RFPs ICON received from its biotechnology customers during the Class Period were used in substantial part as price discovery tools, and thus were not indicative of underlying client demand;
More news about: Law Offices of Howard G. Smith
Mar 19, 2025, 10:32 ET GenScript Unveils Prime Editing Boost with the Broad Institute Deal
N.J., March 19, 2025 /PRNewswire/ -- GenScript Biotech Corp., a global biotechnology leader in life science, biologics manufacturing, synthetic biology, and cell therapies, announced an exciting investment in gene editing technology.
More news about: GenScript Biotech Corporation
Mar 19, 2025, 10:00 ET Porton Advanced Announces Collaboration with Eureka Therapeutics to Accelerate T‑Cell Therapy Development
specializing in advanced therapy medicinal products (ATMPs), is pleased to announce its partnership with Eureka Therapeutics, Inc., a clinical-stage biotechnology company dedicated to developing novel T‑cell therapies for both solid tumors and hematologic malignancies.
More news about: Porton Advanced Solutions
Mar 19, 2025, 09:15 ET REGENXBIO REPORTS POSITIVE BIOMARKER DATA FROM AFFINITY DUCHENNE® TRIAL OF RGX-202 GENE THERAPY
and independence, required support for breathing, cardiomyopathy and premature death. ABOUT REGENXBIO Inc.REGENXBIO is a biotechnology company on a mission to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered the field
More news about: REGENXBIO Inc.
Mar 19, 2025, 09:00 ET InSysBio announces its collaboration with discoveric bio alpha
InSysBio, one of the world's pioneers of Quantitative Systems Pharmacology (QSP) modeling, announces its collaboration with discoveric bio alpha, a biotechnology company taking next generation antibody technologies into Alzheimer's Disease.
More news about: InSysBio
Mar 19, 2025, 07:15 ET Patricia Industries' subsidiary Advanced Instruments to acquire and merge with Nova Biomedical
a manufacturer of innovative analytical instruments and consumables that are vital in guiding the treatment of patients and the development of biotechnology therapeutics.
More news about: Advanced Instruments, LLC
Mar 19, 2025, 07:00 ET Zymo Research Responds to Recent Court Ruling in Litigation with QIAGEN GmbH
proceedings continue. This ruling reinforces Zymo Research's commitment to protecting scientific innovation and ensuring fair competition in the biotechnology sector. As proceedings continue, the company remains focused on delivering cutting-edge sample preparation technologies to the biomedical community
More news about: Zymo Research Corp.
Mar 19, 2025, 07:00 ET Zymo Research Responds to Recent Court Ruling in Litigation with QIAGEN GmbH
proceedings continue. This ruling reinforces Zymo Research's commitment to protecting scientific innovation and ensuring fair competition in the biotechnology sector. As proceedings continue, the company remains focused on delivering cutting-edge sample preparation technologies to the biomedical community
More news about: Zymo Research Corp.
Mar 19, 2025, 07:00 ET ELIAS Animal Health Receives Full Approval from USDA for the ELIAS Cancer Immunotherapy (ECI®), First-In-Class Treatment for Canine Osteosarcoma
www.eliasanimalhealth.com. About ELIAS Animal Health ELIAS Animal Health is a medical biotechnology company focused on advancing a pipeline of immunotherapies, including an adoptive cell therapy and an oncolytic virotherapy, for the treatment of
More news about: ELIAS Animal Health
Mar 19, 2025, 06:00 ET Future Origins and Kao Enter Purchase Agreement for Palm Alternative NALO™
Kao Senior Executive Officer in charge of Chemical Business. Future Origins was founded by industrial biotechnology leader Geno, together with Unilever, Kao, and L'Oréal, to commercialize and manufacture high-volume sustainable ingredients for widely used surfactants
More news about: Future Origins
Mar 19, 2025, 02:56 ET Global Times: Xi inspects Guizhou, stresses high-quality development
Emerging industries in Southwest China's Sichuan, including artificial intelligence, biotechnology, drones, and nuclear technology applications, have experienced rapid growth."As an important part of the western region,
More news about: Global Times
Mar 18, 2025, 17:39 ET DarwinHealth Recognized and Honored as One of the Top 10 Most Innovative Biotech Companies: Named to Fast Company's Prestigious Annual List of the World's Most Innovative Companies of 2025
forward." About DarwinHealth DarwinHealth: Precision Therapeutics for Cancer Medicine is a clinical grade, "frontiers of cancer," biotechnology-focused company, co-founded by CEO Gideon Bosker, MD, and Professor Andrea Califano,
More news about: DarwinHealth
Mar 18, 2025, 17:19 ET DarwinHealth Recognized and Honored as One of the Top 10 Most Innovative Biotech Companies: Named to Fast Company's Prestigious Annual List of the World's Most Innovative Companies of 2025
forward." About DarwinHealth DarwinHealth: Precision Therapeutics for Cancer Medicine is a clinical grade, "frontiers of cancer," biotechnology-focused company, co-founded by CEO Gideon Bosker, MD, and Professor Andrea Califano,
More news about: DarwinHealth